Clarivate enhances cortellis cmc intelligence with post-approval module to accelerate regulatory success

Enhancements enable pharma, biotech and generics companies to streamline regulatory tracking and optimize life cycle management for small molecules and biologics  london , may 2, 2024 /prnewswire/ -- clarivate plc (nyse:clvt), a leading global provider of transformative intelligence, today announced the launch of the newly enhanced cortellis cmc intelligence™ solution, featuring a new post-approval variations module. the module for post-approval variations covers regulatory changes across multiple countries, offering meticulously curated requirements to streamline tracking.
CLVT Ratings Summary
CLVT Quant Ranking